Ultragenyx Pharmaceutical, Inc. (RARE)
36.19
-0.01
(-0.03%)
USD |
NASDAQ |
Dec 12, 10:53
Ultragenyx Pharmaceutical Free Cash Flow: -466.39M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Regeneron Pharmaceuticals, Inc. | 3.881B |
| Amicus Therapeutics, Inc. | 9.691M |
| Geron Corp. | -132.68M |
| Ionis Pharmaceuticals, Inc. | -309.48M |
| Vertex Pharmaceuticals, Inc. | 3.337B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -91.42M |
| Cash from Investing (Quarterly) | 117.18M |
| Cash from Financing (Quarterly) | 0.002M |
| Free Cash Flow Per Share (Quarterly) | -0.9291 |
| Free Cash Flow to Equity (Quarterly) | -72.91M |
| Free Cash Flow to Firm (Quarterly) | -78.48M |
| Free Cash Flow Yield | -13.21% |